BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15037164)

  • 1. Use of an early-detection strategy to improve disease control in melanoma patients.
    Pacifico MD; Grover R; Sanders R
    Br J Plast Surg; 2004 Mar; 57(2):105-11. PubMed ID: 15037164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved malignant melanoma prognosis at a consultant-delivered multidisciplinary pigmented lesion clinic in Cork.
    Field S; Deady S; Fitzgibbon J; Murphy M; Comber H
    Ir Med J; 2010 Feb; 103(2):40-3. PubMed ID: 20666053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the early detection of malignant melanoma.
    Grover R; Ross DA; McKelvie M; Morgan BD
    Ann R Coll Surg Engl; 1996 May; 78(3 ( Pt 1)):176-9. PubMed ID: 8779497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
    Swetter SM; Soon S; Harrington CR; Chen SC
    Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
    Leiter U; Buettner PG; Eigentler TK; Forschner A; Meier F; Garbe C
    Melanoma Res; 2010 Jun; 20(3):240-6. PubMed ID: 20216239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6 year prospective analysis of the diagnosis of malignant melanoma in a pigmented-lesion clinic: even the experts miss malignant melanomas, but not often.
    Duff CG; Melsom D; Rigby HS; Kenealy JM; Townsend PL
    Br J Plast Surg; 2001 Jun; 54(4):317-21. PubMed ID: 11355986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma screening clinics: are we detecting more melanomas or reassuring the worried well?
    Weatherhead SC; Lawrence CM
    Br J Dermatol; 2006 Mar; 154(3):539-41. PubMed ID: 16445788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
    McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
    Francken AB; Shaw HM; Accortt NA; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2007 Jun; 14(6):1924-33. PubMed ID: 17357855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
    Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
    J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
    Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
    Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the introduction of a pigmented lesion clinic on the interval between referral by family practitioner and attendance at hospital.
    Osborne JE; Bourke JF; Holder J; Colloby P; Graham-Brown RA
    Br J Dermatol; 1998 Mar; 138(3):418-21. PubMed ID: 9580792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study.
    Carli P; de Giorgi V; Chiarugi A; Nardini P; Weinstock MA; Crocetti E; Stante M; Giannotti B
    J Am Acad Dermatol; 2004 May; 50(5):683-9. PubMed ID: 15097950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
    Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
    Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.